A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers

British Journal of Haematology

Volumn 151, Issue 5, 2010, Pages 516-524

  McMahon, Lillian ^a   Tamary, Hannah ^b   Askin, Melissa ^a   Adams Graves, Patricia ^c   Eberhardt, Robert T ^a   Sutton, Millicent ^d   Wright, Elizabeth C ^e   Castaneda, Serguei A ^a   Faller, Douglas V ^a   Perrine, Susan P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d NEW YORK BLOOD CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Arginine butyrate; Leg ulcer; Randomized controlled trial; Sickle cell anaemia; Wound healing

Indexed keywords

ANTIEMETIC AGENT; ARGININE BUTYRATE; HEMATOLOGIC AGENT; HYDROXYUREA; IBUPROFEN; PARACETAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED HEADACHE; FEMALE; HUMAN; LEG ULCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTORY SICKLE CELL LEG ULCER; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; TREATMENT RESPONSE; ULCER HEALING; WOUND DRESSING;

ADULT; ANEMIA, SICKLE CELL; ARGININE; BUTYRATES; CHRONIC DISEASE; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 78349240687     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08395.x     Document Type: Article

References (62)

1. Ademiluyi, S.A., Rotimi, V.O., Coker, A.O., Banjo, T.O. & Akinyanju, O. (1988) The anaerobic and aerobic bacterial flora of leg ulcers in patients with sickle-cell disease. Journal of Infection, 17, 115-120.
2. Agarwal, V.P. & Schimmel, E.M. (1989) Diversion colitis: a nutritional deficiency syndrome? Nutrition Reviews, 47, 257-261.
3. Ahrendt, G.M., Gardner, K. & Barbul, A. (1994) Loss of colonic structural collagen impairs healing during intra-abdominal sepsis. Archives of Surgery, 129, 1179-1183.
4. Angele, M.K., Nitsch, S.M., Hatz, R.A., Angele, P., Hernandez-Richter, T., Wichmann, M.W., Chaudry, I.H. & Schildberg, F.W. (2002) L-arginine: a unique amino acid for improving depressed wound immune function following hemorrhage. European Surgical Research, 34, 53-60.
5. Atweh, G.F., Sutton, M., Nassif, I., Boosalis, V., Dover, G.J., Wallenstein, S., Wright, E., McMahon, L., Stamatoyannopoulos, G., Faller, D.V. & Perrine, S.P. (1999) Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood, 93, 1790-1797.
6. Barbul, A., Lazarou, S.A., Efron, D.T., Wasserkrug, H.L. & Efron, G. (1990) Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery, 108, 331-336; discussion 336-337.
7. Brauer, M., Al-Momen, A.K. & Faller, D.V. (1995) Butyrate treatment in beta-hemoglobinopathies. The New England Journal of Medicine, 333, 1287-1288.
8. Caputi, R., Jacobs, A.M. & Oloff, L.M. (1984) Sickle cell anemia in podiatric surgery. Journal of Foot Surgery, 23, 135-145.
9. Chapman, M.A., Grahn, M.F., Hutton, M. & Williams, N.S. (1995) Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis. British Journal of Surgery, 82, 36-38.
10. Diakos, C., Prieschl, E.E., Saemann, M.D., Bohmig, G.A., Csonga, R., Sobanov, Y., Baumruker, T. & Zlabinger, G.J. (2006) n-Butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells. Biochemical and Biophysical Research Communications, 349, 863-868.
11. Dobson, D.E., Kambe, A., Block, E., Dion, T., Lu, H., Castellot, Jr, J.J. & Spiegelman, B.M. (1990) 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell, 61, 223-230.
12. Eckman, J.R. (1996) Leg ulcers in sickle cell disease. Hematology/Oncology Clinics of North America, 10, 1333-1344.
13. Emenaker, N.J. & Basson, M.D. (1998) Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation. Journal of Surgical Research, 76, 41-46.
14. Eming, S.A., Krieg, T. & Davidson, J.M. (2007) Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology, 127, 514-525.
15. Faller, D.V. (1998) Nitric oxide and the regulation of vasoactive genes. In: The Pathophysiology and Clinical Applications of Nitric Oxide (ed. by G. Rubanyi), pp. 121-154. Harwood Academic, Reading, United Kingdom.
16. Gueri, M. & Serjeant, G.R. (1970) Leg ulcers in sickle-cell anaemia. Tropical and Geographical Medicine, 22, 155-160.
17. Holt, D.R., Kirk, S.J., Regan, M.C., Hurson, M., Lindblad, W.J. & Barbul, A. (1992) Effect of age on wound healing in healthy human beings. Surgery, 112, 293-297; discussion 297-298.
18. Jeng, M.R., Feusner, J., Skibola, C. & Vichinsky, E. (2002) Central venous catheter complications in sickle cell disease. American Journal of Hematology, 69, 103-108.
19. Karayalcin, G., Rosner, F., Kim, K.Y., Chandra, P. & Aballi, A.J. (1975) Sickle cell anemia- clinical manifestations in 100 patients and review of the literature. The American Journal of the Medical Sciences, 269, 51-68.
20. Kato, G.J., Gladwin, M.T. & Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 37-47.
21. Kirk, S.J., Hurson, M., Regan, M.C., Holt, D.R., Wasserkrug, H.L. & Barbul, A. (1993) Arginine stimulates wound healing and immune function in elderly human beings. Surgery, 114, 155-159; discussion 160.
22. Koshy, M., Entsuah, R., Koranda, A., Kraus, A.P., Johnson, R., Bellvue, R., Flournoy-Gill, Z. & Levy, P. (1989) Leg ulcers in patients with sickle cell disease. Blood, 74, 1403-1408.
23. Loehe, F., Bruns, C.J., Nitsch, S.M. & Angele, M.K. (2007) The role of L-arginine following trauma and blood loss. Current Opinion in Clinical Nutrition & Metabolic Care, 10, 80-87.
24. Matsumoto, N., Riley, S., Fraser, D., Al-Assaf, S., Ishimura, E., Wolever, T., Phillips, G.O. & Phillips, A.O. (2006) Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)? Kidney International, 69, 257-265.
25. McCready, C.E., Doughty, H.A. & Pearson, T.C. (1996) Experience with the Port-A-Cath in sickle cell disease. Clinical and Laboratory Haematology, 18, 79-82.
26. Menzel, T., Luhrs, H., Zirlik, S., Schauber, J., Kudlich, T., Gerke, T., Gostner, A., Neumann, M., Melcher, R. & Scheppach, W. (2004) Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflammatory Bowel Diseases, 10, 122-128.
27. Morgan, A.G. (1982) Proteinuria and leg ulcers in homozygous sickle cell disease. Journal of Tropical Medicine and Hygiene, 85, 205-208.
28. Mort, J.S. (2005) Histone deacetylases--a new target for suppression of cartilage degradation? Arthritis Research & Therapy, 7, 155-156.
29. Nolan, V.G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D.F., Farrell, J.J., Sebastiani, P., Farrer, L.A. & Steinberg, M.H. (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Bristish Journal of Haematology, 133, 570-578.
30. Oluwasanmi, J.O., Ofodile, F.A. & Akinyemi, O.O. (1980) Leg ulcers in haemoglobinopathies. East African Medical Journal, 57, 60-64.
31. Park, J.S., Lee, E.J., Lee, J.C., Kim, W.K. & Kim, H.S. (2007) Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. International Immunopharmacology, 7, 70-77.
32. Pascher, F. & Keen, R. (1957) Ulcers of the leg in Cooley's anemia. The New England Journal of Medicine, 256, 1220-1222.
33. Perrine, R.P., Pembrey, M.E., John, P., Perrine, S. & Shoup, F. (1978) Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Annals of Internal Medicine, 88, 1-6.
34. Perrine, S.P., Ginder, G.D., Faller, D.V., Dover, G.H., Ikuta, T., Witkowska, H.E., Cai, S.P., Vichinsky, E.P. & Olivieri, N.F. (1993) A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. New England Journal of Medicine, 328, 81-86.
35. Perrine, S.P., Castaneda, S.A., Chui, D.H.K., Faller, D.V., Berenson, R.J., Siritanaratkul, N. & Fucharoen, S. (2010) Fetal globin gene inducers: novel agents and new potential. Annals of The New York Academy of Sciences, 1202, 158-164.
36. Phillips, G., Slingluff, C., Hartman, J., Thomas, P. & Akwari, O. (1988) Totally implantable intravenous catheters in the management of sickle cell anemia. American Journal of Hematology, 29, 134-138.
37. Pope, F.M. & Hodgson, G.A. (1968) Le ulceration and thalassaemia. British Journal of Dermatology, 80, 840.
38. Regan, M.C., Kirk, S.J., Wasserkrug, H.L. & Barbul, A. (1991) The wound environment as a regulator of fibroblast phenotype. Journal of Surgical Research, 50, 442-448.
39. Regan, M.C., Kirk, S.J., Hurson, M., Sodeyama, M., Wasserkrug, H.L. & Barbul, A. (1993) Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery, 113, 173-177.
40. Rizk, M., Witte, M.B. & Barbul, A. (2004) Nitric oxide and wound healing. World Journal of Surgery, 28, 301-306.
41. Roberts, P.R., Black, K.W., Santamauro, J.T. & Zaloga, G.P. (1998) Dietary peptides improve wound healing following surgery. Nutrition, 14, 266-269.
42. Roediger, W.E. (1990) The starved colon--diminished mucosal nutrition, diminished absorption, and colitis. Diseases of the Colon & Rectum, 33, 858-862.
43. Saito, S., Trovato, M.J., You, R., Lal, B.K., Fasehun, F., Padberg, Jr, F.T., Hobson, II, R.W., Duran, W.N. & Pappas, P.J. (2001) Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. Journal of Vascular Surgery, 34, 930-938.
44. Schaffer, M.R., Tantry, U., Ahrendt, G.M., Wasserkrug, H.L. & Barbul, A. (1997) Stimulation of fibroblast proliferation and matrix contraction by wound fluid. The International Journal of Biochemistry & Cell Biology, 29, 231-239.
45. Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G.M., Bartram, P., Christl, S., Richter, F., Dusel, G. & Kasper, H. (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology, 103, 51-56.
46. Segain, J.P., Raingeard de la Bletiere, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottiere, H.M. & Galmiche, J.P. (2000) Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut, 47, 397-403.
47. Serjeant, G.R. & Howard, C. (1977) Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration. West Indian Medical Journal, 26, 164-166.
48. Serjeant, G.R., Galloway, R.E. & Gueri, M.C. (1970) Oral zinc sulphate in sickle-cell ulcers. Lancet, 2, 891-892.
49. Shearer, J.D., Richards, J.R., Mills, C.D. & Caldwell, M.D. (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. American Journal of Physiology, 272, E181-E190.
50. Shi, H.P., Wang, S.M., Zhang, G.X., Zhang, Y.J. & Barbul, A. (2007) Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock. Wound Repair and Regeneration, 15, 66-70.
51. Steinberg, M.H. (2005) Predicting clinical severity in sickle cell anaemia. Bristish Journal of Haematology, 129, 465-481.
52. Sutton, M., Atweh, G.F., Mazza, P., Dover, G.J., Ballas, S.K., Daftari, P., Mays, A. & Perrine, S. (1994) Reversal of organ damage on arginine butyrate therapy [abstract 2221]. Blood, 84, 559a.
53. Taher, A.T., Musallam, K.M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.S., El-Chafic, A.H., Fasulo, M.R. & Cappellini, M.D. (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood, 115, 1886-1892.
54. Tang, S.J., Ko, L.W., Lee, Y.H. & Wang, F.F. (1990) Induction of fos and sis proto-oncogenes and genes of the extracellular matrix proteins during butyrate induced glioma differentiation. Biochimica et Biophysica Acta, 1048, 59-65.
55. Tong, B.C. & Barbul, A. (2004) Cellular and physiological effects of arginine. Mini-Reviews in Medicinal Chemistry, 4, 823-832.
56. Ulland, A.E., Shearer, J.D., Coulter, C. & Caldwell, M.D. (1997) Altered wound arginine metabolism by corticosterone and retinoic acid. Journal of Surgical Research, 70, 84-88.
57. Vernia, P., Cittadini, M., Caprilli, R. & Torsoli, A. (1995) Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate. Digestive Diseases and Sciences, 40, 305-307.
58. Walshe, M.M. & Milner, P.F. (1967) The management of leg ulcers in sickle cell anaemia. West Indian Medical Journal, 16, 10-16.
59. Wang, X.J., Han, G., Owens, P., Siddiqui, Y. & Li, A.G. (2006) Role of TGF beta-mediated inflammation in cutaneous wound healing. Journal of Investigative Dermatology Symposium Proceedings, 11, 112-117.
60. Wethers, D.L., Ramirez, G.M., Koshy, M., Steinberg, M.H., Phillips, Jr, G., Siegel, R.S., Eckman, J.R. & Prchal, J.T. (1994) Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood, 84, 1775-1779.
61. Wysocki, A.B., Staiano-Coico, L. & Grinnell, F. (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. Journal of Investigative Dermatology, 101, 64-68.
62. Young, D.A., Lakey, R.L., Pennington, C.J., Jones, D., Kevorkian, L., Edwards, D.R., Cawston, T.E. & Clark, I.M. (2005) Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Research & Therapy, 7, R503-R512.